Newsroom
Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has filed the annual report 2020 on form 20-F with the U.S. Securities and Exchange Commission (SEC).
Throughout 2020, Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, reported COVID-19 affecting patients with advanced kidney disease and, in particular, the severity of illness resulting in an increased mortality.
Fresenius Medical Care has improved in this year's ranking of the non-profit organization CDP (formerly "Carbon Disclosure Project").
Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure, has been recognized for the 11th time as a sustainability leader with inclusion in the Dow Jones Sustainability Index (DJSI Europe).
Fresenius Medical Care North America announced a partnership with Livongo, the leading Applied Health Signals company in the U.S.